Ventilation Measurement Using Tracers for Control of Infectious Aerosols
Ventilation Measurement Using Tracers for Control of Infectious Aerosols
Abstract:
Join this session to learn about the opportunity for AABC members to support building operators in new indoor air standards hitting building codes. The good news is that measuring equivalent Air Changes per Hour (also known as eACH) is not only a way to meet the coming building standard and help occupants stay healthy from airborne viruses, but also help clients meet ESG goals and reduce energy costs.
Learning objectives:
Understand the latest standard being rolled out in local building codes for all commercial buildings
Learn how measuring air changes can help occupants reduce the risk of transmission of respiratory illnesses
Learn how measuring air changes can help your clients save energy costs and meet their environmental goals
Learn a new fast and accurate technique to measure against the standard using tracer particles and sensors
Sponsored by:
When it comes to the safety of your indoor air, you can’t improve what you can’t measure. That’s why Poppy provides the technology and expertise you need to do just that: discover exactly what’s in the air around you, at any time and in any place, so what was invisible becomes visible, measurable, and, most importantly, fixable. As a result, our system delivers unparalleled indoor air safety, increased occupant confidence, and greater energy efficiency. The intelligence we provide helps enterprises bring together safety and sustainability in one place: your indoor workspaces and buildings.
An entrepreneur and innovative scientist, Sam Molyneux is co-CEO and Co-Founder of Poppy Health. Poppy is the indoor health company. Providing instant, accurate air safety monitoring for any indoor space, Poppy is used by commercial properties and corporations to keep buildings sustainable and occupants healthy.
Prior to co-founding Poppy, Sam was an executive at Chan Zuckerberg, and CEO and Co-Founder of Meta. Sam is an experienced entrepreneur and scientist specializing in bringing mission-driven, science-forward ventures to market. Recently he’s been recognized as Canada’s Top 40 Under 40, and one of Fast Company’s Most Creative People in Business. Sam’s research has been published in Nature Genetics, Science Translational Medicine, Cancer Cell and other leading journals, and he is a frequent speaker on the future of innovation, and science-based technology for good.
